Here it is2 Sep 2016 09:34
Hello Share Squaddies. May I bring to your attention another medical outfit which has a very encouraging market to have a go at. The firm is Concepta (CPT) and it has produced something it calls MyLotus. These are clever devices which test fertility in women, as well as being an indicator of pregnancy.
It’s something to do with hormones and urine samples, but of course, the details are beyond me. The kits are not likely to be very cheap and could sell for about £250 on a commercial basis. However we know, don’t we, that people will usually stump up where their health and welfare is concerned.
There is no permission to sell MyLotus kits in the UK, or indeed Europe, but this is expected in 2017. And in China the kits have the green light and will go on sale there this year. A selling network is already in place for that.
Also, Concepta has other irons in the fire of medical pioneering. It is working on kits to diagnose stress. Though this is linked to the effects of stress on fertility, it may have a wider customer base, including men.
Stress is always hard to prove and devices to detect it would be useful. One imagines, perhaps, it could be employed to persuade cynical bosses that you really can’t work at the moment.
The City seems to quite like this company: the shares rose by about 50% last month alone. It’s an AIM member, based in York, and the market cap is about £20m.
The Chairman Adam Reynolds says it aims to become a global leader in over-the-counter fertility products. And he reckons the firm could come in early on a connected global healthcare market worth $60 billion dollars by 2020.
I know that sort of hope is easy to express, but you never know.
As we always say in the Punter’s Return.
- See more at: http://www.*************.com/views/23410/a-huge-market-awaits-fertility-pioneer-concepta#sthash.dE8Pju22.dpuf
Sign In
Follow the stocks
